Ascending Ramp Waveforms for ICD Energy Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter defibrillators (ICDs) face limitations in effectively managing cardiac arrhythmias like ventricular fibrillation (VF), ventricular tachycardia (VT), and atrial fibrillation (AF) due to their reliance on biphasic truncated exponential waveforms, which may not provide optimal energy delivery and can cause discomfort to patients, and are prone to lead wire failures.
Innovation Solution
The development of an amplifier-based subcutaneous and transvenous ICD system that uses a single-wire to deliver arbitrary biphasic ascending waveforms, allowing for constant current, voltage, or energy modes, with software-controlled waveform adjustments to optimize energy delivery and reduce cardiac damage, and the ability to switch between different waveform geometries for enhanced conversion efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biphasic truncated exponential waveforms are used in current ICDs, then defibrillation can be delivered, but energy delivery is not optimal and patient discomfort increases
Solution Approach 1:
The patent changes the waveform parameters from traditional biphasic truncated exponential to ascending ramp waveforms with controlled rise times and durations. This parameter modification delivers defibrillation energy more effectively while reducing peak currents and patient discomfort, directly resolving the contradiction between reliability and harmful effects.
2Reliability
If traditional ICD waveforms are used, then defibrillation function is provided, but cardiac damage occurs as indicated by troponin I enzyme levels
Solution Approach 1:
The patent modifies waveform parameters including extending duration and controlling rise times to deliver energy more gradually. This reduces myocardial damage and troponin I release while maintaining defibrillation efficacy, resolving the contradiction between providing defibrillation function and preventing cardiac damage.
3Device complexity
If fixed waveform geometry is used in ICDs, then device simplicity is maintained, but adaptability to different arrhythmias and patient conditions is limited
Solution Approach 1:
The patent implements dynamic waveform generation where the ascending ramp parameters (duration, rise time, amplitude) can be adjusted based on detected arrhythmia type and patient impedance. This allows the same device to adapt to different clinical scenarios without increasing fundamental system complexity, resolving the contradiction between device simplicity and adaptability.
4Speed
If rapid energy delivery is used, then defibrillation shock is delivered quickly, but cardiac damage increases and patient discomfort rises
Solution Approach 1:
The patent uses controlled periodic ascending ramp waveforms that deliver energy in a structured sequence with specific rise times and durations. This periodic delivery method spreads energy input over time, reducing peak power density and its harmful effects while maintaining overall defibrillation effectiveness, thus resolving the contradiction between delivery speed and harmful factors.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces troponin I enzyme levels, indicating less cardiac damage, and allows for more effective cardioversion and defibrillation with reduced peak voltages and slower energy delivery, improving the treatment of cardiac arrhythmias while minimizing patient discomfort and lead wire failures.
Implementation Method 1
deliver arbitrary biphasic ascending waveforms... constant current, voltage, or energy modes
Data Source
AI summary
Cardiac defibrillation or cardioversion waveform energy control systems employ transvenous ICDs, subcutaneous SICDs, or pacemakers for treating cardiac conditions. The systems comprise differentially driven amplifier circuit operational modes to control the delivery of pacing, anti-tachycardia pacing, defibrillation, and/or cardioversion electrical shocks, wherein the pacing, anti-tachycardia pacing, and shock waveforms employ constant current, constant voltage, or constant energy. Biphasic arbitrary shock waveforms deliver increasing energy with increasing time as represented by phase 1 ascending ramp, ascending exponential, ascending chopped, ascending stepped, ascending curved, square, or rectilinear and/or any combination of geometric shaped ascending arbitrary waveforms or any BTE waveform.


